Professional Records
License Records
John Paul Penhune
Address:
6730 Muirlands Dr, La Jolla, CA 92037
License #:
A1471831
Category:
Airmen
John Penhune Phones & Addresses
-
San Diego, CA
-
20 Alaeloa Pl, Lahaina, HI 96761 (808) 669-0019
-
20 Hui Rd E, Lahaina, HI 96761
-
20 Hui Rd I, Lahaina, HI 96761
-
6730 Muirlands Dr, La Jolla, CA 92037 (858) 459-7402
Work
Position:
Principal
Education
School / High School:
Harvard Business School 1973 to 1973
Specialities:
Management
Skills
Start Ups • Management Consulting • Program Development • Integration • Management • Business Development • Strategy • Project Management • Biotechnology • Analysis • Government • Team Building • Research • Program Management • Leadership • Project Planning • Proposal Writing • Strategic Planning • Software Development • Corporate Development • Entrepreneurship
Languages
French
Industries
Research
Resumes
Resumes
Principal
View pageLocation:
San Diego, CA
Industry:
Research
Work:
Principal
Education:
Harvard Business School 1973 - 1973
Massachusetts Institute of Technology 1953 - 1961
Doctorates, Doctor of Philosophy, Electrical Engineering
Massachusetts Institute of Technology 1953 - 1961
Doctorates, Doctor of Philosophy, Electrical Engineering
Skills:
Start Ups
Management Consulting
Program Development
Integration
Management
Business Development
Strategy
Project Management
Biotechnology
Analysis
Government
Team Building
Research
Program Management
Leadership
Project Planning
Proposal Writing
Strategic Planning
Software Development
Corporate Development
Entrepreneurship
Management Consulting
Program Development
Integration
Management
Business Development
Strategy
Project Management
Biotechnology
Analysis
Government
Team Building
Research
Program Management
Leadership
Project Planning
Proposal Writing
Strategic Planning
Software Development
Corporate Development
Entrepreneurship
Languages:
French
Business Records
Name / Title
Company / Classification
Phones & Addresses
Principal
EMPRESS LAHAINA, LLC
Nonclassifiable Establishments
Nonclassifiable Establishments
1050 Rosecrans St STE 4, San Diego, CA 92106
942 Windemere Dr NW, Salem, OR 97304
942 Windemere Dr NW, Salem, OR 97304
Publications
Us Patents
Methods And Apparatus For Genetic Evaluation
View pageUS Patent:
20040209260, Oct 21, 2004
Filed:
Apr 18, 2003
Appl. No.:
10/418514
Inventors:
David Ecker - Encinitas CA, US
Richard Griffey - Vista CA, US
Rangarajan Sampath - San Diego CA, US
Steven Hofstadler - Oceanside CA, US
John McNeil - La Jolla CA, US
Stanley Crooke - Carlsbad CA, US
Dino Sofianos - San Diego CA, US
Karl Rudnick - Solana Beach CA, US
Duane Knize - La Jolla CA, US
Roland Stoughton - San Diego CA, US
Cecil Basham - Del Mar CA, US
Clifford Lewis - San Diego CA, US
Brons Larson - Santee CA, US
Jonathan Bar-on - San Diego CA, US
Dennis Murray - Culver City CA, US
David Robbins - San Diego CA, US
John Penhune - La Jolla CA, US
Richard Griffey - Vista CA, US
Rangarajan Sampath - San Diego CA, US
Steven Hofstadler - Oceanside CA, US
John McNeil - La Jolla CA, US
Stanley Crooke - Carlsbad CA, US
Dino Sofianos - San Diego CA, US
Karl Rudnick - Solana Beach CA, US
Duane Knize - La Jolla CA, US
Roland Stoughton - San Diego CA, US
Cecil Basham - Del Mar CA, US
Clifford Lewis - San Diego CA, US
Brons Larson - Santee CA, US
Jonathan Bar-on - San Diego CA, US
Dennis Murray - Culver City CA, US
David Robbins - San Diego CA, US
John Penhune - La Jolla CA, US
International Classification:
C12Q001/68
G06F019/00
G01N033/48
G01N033/50
G06F019/00
G01N033/48
G01N033/50
US Classification:
435/006000, 702/020000
Abstract:
Rapid and definitive bioagent detection and identification can be carried out without nucleic acid sequencing. Analysis of a variety of bioagents and samples, such as air, fluid, and body samples, can be carried out to provide information useful for industrial, medical, and environmental purposes. Nucleic acid samples of unknown or suspected bioagents may be collected, optimal primer pairs may be selected, and the nucleic acid may be amplified. Expected mass spectra signal models may be generated and selected, the actual mass spectra of the amplicons may be obtained. The expected mass spectra most closely correlating with the actual mass spectra may be determined using a joint maximum likelihood analysis, and base counts for the actual mass spectra and the expected mass spectra may be obtained. The most likely candidate bioagents may then be determined.
Methods And Apparatus For Genetic Evaluation
View pageUS Patent:
20120095696, Apr 19, 2012
Filed:
Sep 23, 2011
Appl. No.:
13/243912
Inventors:
David J. Ecker - Encinitas CA, US
Richard H. Griffey - Vista CA, US
Rangarajan Sampath - San Diego CA, US
Steven A. Hofstadler - Vista CA, US
John McNeil - La Jolla CA, US
Stanley T. Crooke - Carlsbad CA, US
Dino J. Sofianos - San Diego CA, US
Karl H. Rudnick - Solana Beach CA, US
Duane J. Knize - San Diego CA, US
Roland B. Stoughton - San Diego CA, US
Clifford T. Lewis - San Diego CA, US
Brons M. Larson - Santee CA, US
Jonathan R. Bar-on - San Diego CA, US
Dennis P. Murray - Culver City CA, US
David W. Robbins - San Diego CA, US
John P. Penhune - La Jolla CA, US
Richard H. Griffey - Vista CA, US
Rangarajan Sampath - San Diego CA, US
Steven A. Hofstadler - Vista CA, US
John McNeil - La Jolla CA, US
Stanley T. Crooke - Carlsbad CA, US
Dino J. Sofianos - San Diego CA, US
Karl H. Rudnick - Solana Beach CA, US
Duane J. Knize - San Diego CA, US
Roland B. Stoughton - San Diego CA, US
Clifford T. Lewis - San Diego CA, US
Brons M. Larson - Santee CA, US
Jonathan R. Bar-on - San Diego CA, US
Dennis P. Murray - Culver City CA, US
David W. Robbins - San Diego CA, US
John P. Penhune - La Jolla CA, US
Assignee:
IBIS BIOSCIENCES, INC. - Carlsbad CA
International Classification:
G06F 19/22
US Classification:
702 20
Abstract:
Rapid and definitive bioagent detection and identification can be carried out without nucleic acid sequencing. Analysis of a variety of bioagents and samples, such as air, fluid, and body samples, can be carried out to provide information useful for industrial, medical, and environmental purposes. Nucleic acid samples of unknown or suspected bioagents may be collected, optimal primer pairs may be selected, and the nucleic acid may be amplified. Expected mass spectra signal models may be generated and selected, the actual mass spectra of the amplicons may be obtained. The expected mass spectra most closely correlating with the actual mass spectra may be determined using a joint maximum likelihood analysis, and base counts for the actual mass spectra and the expected mass spectra may be obtained. The most likely candidate bioagents may then be determined.
Frequency Domain Active Noise Cancellation System And Method
View pageUS Patent:
20140314241, Oct 23, 2014
Filed:
Aug 1, 2013
Appl. No.:
13/957389
Inventors:
- San Diego CA, US
John Penhune - La Jolla CA, US
John Penhune - La Jolla CA, US
Assignee:
VOR Data Systems, Inc. - San Diego CA
International Classification:
G10K 11/175
US Classification:
381 711
Abstract:
A frequency domain active noise cancellation system and method are provided that achieves superior active reduction of offending noise sources. The frequency-domain active noise cancellation identifies and cancels one or more of the strongest relatively narrow frequency bands in the power spectra of the offending sound sources.